Role of economic evidence in coverage decision-making in South Korea.

ABSTRACT:

Objectives

The South Korean government required the submission of economic evidence when it implemented the Positive-List System in December 2006. This study investigates the key factors that influenced actual public insurance reimbursement decisions, including the role of economic evidence, after 10 years of decision practice under compulsory health technology assessment (HTA) for new drugs.

Method

Logistic regression analysis was used to estimate the impact of the variables involved, including cost-effectiveness ratio as a key variable, on reimbursement decisions. The latter were defined as "yes" or "no" at a submitted price and indication. Only cases (n = 91) that present a cost-effectiveness ratio, and that have been reviewed based on this ratio from January 2007 to Dece

SUBMITTER: Bae EY 

PROVIDER: S-EPMC6200251 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature